Skip to main navigation

About Us
Our Science
- Our Approach
- Our Focus
  - CLL
  - MS
  - MZL/FL
- Collaborate with Us
Our Pipeline
- Overview
- UBLITUXIMAB
- UMBRALISIB
- TG-1501
- TG-1701
- TG-1801
Our Publications
Our Trials
- Trial Information
- Expanded Access Policy
Investors & Media

CAREERS
CONTACT US
Twitter

Close

About Us
Our Science
- Our Approach
- Our Focus
  - CLL
  - MS
  - MZL/FL
- Collaborate with Us
Our Pipeline
- Overview
- UBLITUXIMAB
- UMBRALISIB
- TG-1501
- TG-1701
- TG-1801
Our Publications
Our Trials
- Trial Information
- Expanded Access Policy
Investors & Media

Investors
& Media

Event Details

First Quarter 2017 Earnings Results

May 05, 2017 at 8:30 AM EDT

Listen to webcast

Share facebook linkedin twitter

Component-5--2

2 Gansevoort Street, 9th Floor
New York, NY 10014

Email Us (212) 554-4484

TG Therapeutics © . All rights reserved.

Join us
Contact Us
Privacy Policy
Terms of Use